PRO - LA decompression is unnecessary in the era of SGLT2 inhibitors and ARNI's!
We Recommend
Disclosures
Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:
- Equity/Stock(s)/Options (Personal) - Gilead Sciences
- Grant Support/Research Contract (Institutional) - Boston Scientific Corporation; Medtronic; Array BioPharma; Ionis Pharmaceuticals, Inc.; Novartis; MyoKardia; Merck/Schering Plough